Angiogenesis Inhibitors: all 4,430 studies that test it

Page 17 of 45. Open to participants first (542), then studies with results posted, then the rest; newest registration first within each.

• Treatment With Intravitreal Avastin for Large Uveal MelanomasCompletedNCT00596362Not applicableResults posted
• Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin TrialCompletedNCT00593450Phase 3Results posted
• RAD001 Plus Bevacizumab in Metastatic MelanomaCompletedNCT00591734Phase 2Results posted
• Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma MultiformeCompletedNCT00590681Phase 2Results posted
• Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable MeningiomaCompletedNCT00589784Phase 2Results posted
• Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT00588770Phase 3Results posted
• Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial CarcinomaCompletedNCT00588666Phase 2Results posted
• Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube CancerCompletedNCT00588237Phase 2Results posted
• Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant GliomasCompletedNCT00586508Phase 2Results posted
• Bevacizumab (Avastin®) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent, Non-squamous Cell Lung CancerCompletedNCT00585377Phase 2Results posted
• Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer PatientsTerminatedNCT00583622Phase 2Results posted
• Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast CancerCompletedNCT00580333Phase 2Results posted
• SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous MelanomaCompletedNCT00577382Phase 2Results posted
• OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.CompletedNCT00577031Phase 4Results posted
• A Study of Avastin (Bevacizumab) and Transarterial Chemoembolisation (TACE) Treatment in Patients With Liver CancerCompletedNCT00576199Phase 2Results posted
• Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic CancerTerminatedNCT00574275Phase 3Results posted
• Brain Mets - Capecitabine Plus Sunitinib and WBRTTerminatedNCT00570908Phase 2Results posted
• Phase II Trial for Patients With Loco-Regional Esophageal CarcinomaTerminatedNCT00570531Phase 2Results posted
• Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine TumorActive, not recruitingNCT00569127Phase 3Results posted
• Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple MyelomaTerminatedNCT00567229Phase 2Results posted
• Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube CancerActive, not recruitingNCT00565851Phase 3Results posted
• Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic AmyloidosisCompletedNCT00564889Phase 2Results posted
• Ranibizumab Therapy for Non-arteritic Ischemic Optic NeuropathyCompletedNCT00561834Phase 1Results posted
• Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based RegimenCompletedNCT00561470Phase 3Results posted
• Topical Avastin for Treatment of Corneal NeovascularizationCompletedNCT00559936Phase 1Results posted
• A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast CancerCompletedNCT00559845Phase 2Results posted
• CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or AmyloidosisCompletedNCT00558896Phase 2Results posted
• Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas CancerCompletedNCT00557492Phase 2Results posted
• Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell CarcinomaCompletedNCT00556049Phase 2Results posted
• Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric CancerCompletedNCT00555672Phase 1Results posted
• Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00553800Phase 2Results posted
• Study Of Sunitinib With S-1 And Cisplatin For Gastric CancerCompletedNCT00553696Phase 1Results posted
• Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell LymphomaCompletedNCT00553644Phase 2Results posted
• A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric CancerCompletedNCT00548548Phase 3Results posted
• Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical CancerCompletedNCT00548418Phase 2Results posted
• Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal DetachmentCompletedNCT00548197Phase 1Results posted
• Lenalidomide in Older Patients With Acute Myeloid Leukemia Without Chromosome 5q AbnormalitiesCompletedNCT00546897Phase 2Results posted
• Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast CancerCompletedNCT00546156Phase 2Results posted
• Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological CancersCompletedNCT00545792Phase 2Results posted
• Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal WomenCompletedNCT00545077Phase 3Results posted
• Bevacizumab and Docetaxel in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00541099Phase 2Results posted
• Phase II Study of Revlimid®, Oral Cyclophosphamide and Prednisone for Patients With Newly Diagnosed Multiple MyelomaCompletedNCT00540644Phase 2Results posted
• CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the PancreasCompletedNCT00540579Phase 1/2Results posted
• Lenalidomide in Relapsed or Refractory Classical Hodgkin LymphomaCompletedNCT00540007Phase 2Results posted
• Changes in Retinal Function After Intravitreal Ranibizumab for Age-related Macular DegenerationCompletedNCT00539734Not applicableResults posted
• Phase II Study of Dexamethasone, Thalidomide and Lenalidomide for Subjects With Relapsed or Refractory Multiple MyelomaTerminatedNCT00538824Phase 2Results posted
• Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple MyelomaCompletedNCT00538733Phase 2Results posted
• Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver InvolvementTerminatedNCT00537823Phase 2Results posted
• A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and EtoposideTerminatedNCT00537511Phase 1/2Results posted
• Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRICompletedNCT00537056Not applicableResults posted
• Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL)CompletedNCT00536341Phase 1/2Results posted
• Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and OlderCompletedNCT00535873Phase 2Results posted
• A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung CancerCompletedNCT00532155Phase 3Results posted
• Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast CancerCompletedNCT00530868Phase 2Results posted
• The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis PatientsTerminatedNCT00529633Phase 3Results posted
• BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast CancerCompletedNCT00528567Phase 3Results posted
• Sunitinib in Treating Patients With Locally Advanced Bladder CancerCompletedNCT00526656Phase 2Results posted
• Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or GliosarcomaCompletedNCT00525525Phase 2Results posted
• Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryTerminatedNCT00524316Phase 2Results posted
• Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple MyelomaCompletedNCT00523848Phase 2Results posted
• Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid TumorTerminatedNCT00523809Phase 2Results posted
• Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With DexamethasoneTerminatedNCT00522392Phase 3Results posted
• Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEUTerminatedNCT00520975Phase 3Results posted
• A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer.CompletedNCT00520403Phase 2Results posted
• Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid CancerCompletedNCT00519896Phase 2Results posted
• Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate CancerCompletedNCT00519285Phase 3Results posted
• Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLCCompletedNCT00517595Phase 2Results posted
• Phase II Study of Carboplatin and Bevacizumab (Avastin) for ER Neg, PR Neg, and HER2/Neu Neg Metastatic Breast CancerTerminatedNCT00517361Phase 2Results posted
• Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing SarcomaCompletedNCT00516295Phase 2Results posted
• A Study of Ramucirumab in Participants With Metastatic Renal Cell CarcinomaCompletedNCT00515697Phase 2Results posted
• Sunitinib in Treating Patients With Relapsed Multiple MyelomaCompletedNCT00514137Phase 2Results posted
• Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial CarcinomaCompletedNCT00513786Phase 2Results posted
• Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast CancerCompletedNCT00513695Phase 2Results posted
• Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal NeovascularizationCompletedNCT00512876Not applicableResults posted
• Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian CancerCompletedNCT00511992Phase 2Results posted
• Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)CompletedNCT00509795Phase 3Results posted
• Aflibercept in Treating Patients With Myelodysplastic SyndromesTerminatedNCT00509249Phase 2Results posted
• Folfox-B Study for Patients With Colorectal Liver MetastasesTerminatedNCT00508872Phase 2Results posted
• Phase 1/2 Study of VELCADE® in Combination With Other Drugs to Treat Previously Untreated Multiple Myeloma PatientsCompletedNCT00507442Phase 1/2Results posted
• Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and PrednisoneCompletedNCT00507416Phase 3Results posted
• Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial CancerCompletedNCT00506155Phase 2Results posted
• Biochemotherapy With Temozolomide for Metastatic MelanomaTerminatedNCT00505635Phase 2Results posted
• Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum CarcinomaCompletedNCT00504257Phase 2Results posted
• Abraxane, Avastin, and Gemcitabine as First-Line Therapy for Patients With Metastatic Breast CancerCompletedNCT00503906Phase 2Results posted
• Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant GliomaCompletedNCT00501891Phase 2Results posted
• Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With DocetaxelCompletedNCT00499694Not applicableResults posted
• Sunitinib in Treating Patients With Recurrent Malignant GliomasCompletedNCT00499473Phase 2Results posted
• Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line TherapyTerminatedNCT00499369Phase 3Results posted
• Lucentis for Inflammatory Macular Edema TrialCompletedNCT00498355Phase 1/2Results posted
• Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell CarcinomaCompletedNCT00496587Phase 2Results posted
• Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)TerminatedNCT00495625Phase 2Results posted
• Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerCompletedNCT00492089Phase 2Results posted
• A Study Evaluating the Efficacy and Safety of Sunitinib With or Without Bevacizumab in First-Line Patients With Metastatic Renal Cell Cancer (SABRE-R)TerminatedNCT00491738Phase 2Results posted
• A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell LymphomaTerminatedNCT00486759Phase 3Results posted
• A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO)CompletedNCT00486018Phase 3Results posted
• A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE)CompletedNCT00485836Phase 3Results posted
• A Study of Bevacizumab (Avastin) in Combination With Capecitabine (Xeloda) in Elderly Patients With Metastatic Colorectal CancerCompletedNCT00484939Phase 3Results posted
• Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye MelanomaTerminatedNCT00482911Phase 2Results posted
• Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast CancerCompletedNCT00479674Phase 2Results posted
• A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple MyelomaCompletedNCT00478777Phase 3Results posted

← Angiogenesis Inhibitors overview